SARA AKIN: Open Payments
NPI 1841904273 · BOERNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 40 payments from 10 companies in 2025. Trend: 2023 $1,261 · 2024 $1,068 · 2025 $708
Food & beverage: $708
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $292 |
| Axsome Therapeutics, Inc. | 9 | $222 |
| Globus Medical, Inc. | 1 | $36 |
| Novo Nordisk Inc | 2 | $32 |
| PFIZER INC. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
Products named: Auvelity, VRAYLAR, UBRELVY, QULIPTA, REXULTI, Senza, TRELEGY ELLIPTA, JARDIANCE.
Industry payments across TX — which companies pay providers there.
